Klaus Dembowsky MD, PhD

Dr. Klaus Dembowsky has more than 25 years experience in research and development for pharmaceutical and biotech companies. After earning his medical degree in Heidelberg he was working in neurophysiological research and habilitated in 1988. He continued his career in the pharmaceutical industry where numerous innovative drugs were brought into clinical development under his leadership, one drug being on the market.

After more than 10 years in the cardiovascular research institute at Bayer he served in different management positions in the biotech industry (VP Drug Discovery at Ingenium Pharmaceuticals, Managing Director at Speedel Experimenta, Chief Medical Officer at Polyphor). In May 2015 he was appointed CEO of amcure and strengthens the management team with his broad experience.